Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Review

Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

       
Total article views   HTML views PDF downloads Totals
8,811 Dovepress* 8,811+ 2,712 11,523
Totals 8,811 2,712 11,523
*Since 13 March 2012
+Since July 2016

View citations on Google Scholar